SCHEMBL58001

SCHEMBL58001

[S]c1nc2ccccc2[nH]1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.60
▸ KDM4E B2RXH2 3/20 0.60
▸ NPC1 O15118 2/20 0.60
▸ RAB9A P51151 2/20 0.60
▸ NPSR1 Q6W5P4 2/20 0.60
▸ ABCB11 O95342 1/20 0.60
▸ TP53 P04637 1/20 0.60
▸ PKM P14618 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ HSD17B10 Q99714 1/20 0.60
▸ MASP2 O00187 1/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ NUDT1 P36639 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ AOC3 Q16853 1/20 0.56
▸ GAA P10253 3/20 0.52
▸ POLB P06746 3/20 0.50
▸ IDO1 P14902 1/20 0.50
▸ DDAH1 O94760 1/20 0.50
▸ NSD2 O96028 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1872555 1.00 ALDH1A1 (0.60) ALDH1A1KDM4ENPC1RAB9ANPSR1
SCHEMBL30634854 0.75 NPC1 (1.00) ALDH1A1KDM4ENPC1RAB9ANPSR1
SCHEMBL30561047 0.75 NPC1 (1.00) ALDH1A1KDM4ENPC1RAB9ANPSR1
SCHEMBL172216 0.75 NPC1 (1.00) ALDH1A1KDM4ENPC1RAB9ANPSR1
SCHEMBL29034384 0.73 ALDH1A1 (0.62) ALDH1A1KDM4ENPC1RAB9ANPSR1
Water SCHEMBL9817804 0.73 NPC1 (0.95) ALDH1A1KDM4ENPC1RAB9ANPSR1
SCHEMBL2706718 0.71 ALDH1A1 (0.60) ALDH1A1KDM4ENPC1RAB9ANPSR1
SCHEMBL277761 0.71 ALDH1A1 (0.60) ALDH1A1KDM4ENPC1RAB9ANPSR1
SCHEMBL460600 0.71 ALDH1A1 (0.61) ALDH1A1KDM4ENPC1RAB9ANPSR1
SCHEMBL2589250 0.71 ALDH1A1 (0.60) ALDH1A1KDM4ENPC1RAB9ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1450 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110655526-A Cephalosporin-siderophore conjugates and methods of preparation and use thereof 中国科学院上海药物研究所 2020-01-07 — — CN claimed
US-10000450-B2 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2018-06-19 — — US claimed
US-20170166524-A1 N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2017-06-15 — — US claimed
US-9611214-B2 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2017-04-04 — — US claimed
US-20140288065-A1 N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-09-25 — — US claimed
US-8815871-B2 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-08-26 — — US claimed
US-20130203750-A1 N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-08-08 — — US claimed
US-20120065162-A1 N-N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2012-03-15 — — US claimed
EP-2303283-A2 ANTI-CANCER COMBINATION THERAPY Katholieke Universiteit Leuven K.U. Leuven R&D (BE) 2011-04-06 — — EP claimed
US-20110065663-A1 ANTI-CANCER COMBINATION THERAPY KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D 2011-03-17 — — US claimed
US-4410522-A BACTERICIDES TOYAMA CHEMICAL CO., LTD. (JP) 1983-10-18 — — US claimed
US-4393060-A ANTICANCER HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1983-07-12 — — US claimed
US-4385169-A Reactive alpha amino acid polymer TEIJIN LIMITED (JP) 1983-05-24 — — US claimed
EP-0029202-B1 NOVEL TETRAZOLE-5-THIOL ESTERS AND PROCESS FOR PREPARING CEFAMANDOLE USING SAME Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1983-04-13 — — EP claimed
EP-0047014-A2 Novel thioesters and process for the preparation of the same Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1982-03-10 — — EP claimed
EP-0040506-A2 Reactive polymer and process for the preparation thereof TEIJIN LIMITED (JP) 1981-11-25 — — EP claimed
EP-0029202-A1 Novel tetrazole-5-thiol esters and process for preparing cefamandole using same Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1981-05-27 — — EP claimed
US-4200744-A Substituted 7α-methoxy-7β[(2,3-dioxo-1-piperazinyl)carbonylaminophenylacetamido]cephalosporins TOYAMA CHEMICAL COMPANY, LIMITED (JP) 1980-04-29 — — US claimed
US-4039536-A 7-(α-SUBSTITUTED GLYCINAMIDO)-3-SUBSTITUTED METHYL-3-CEPHEM-4-CARBOXYLIC ACIDS AND THEIR DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JA) 1977-08-02 — — US claimed
US-3930866-A MAGENTA FUJI PHOTO FILM CO., LTD. (JA) 1976-01-06 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130203750-A1 N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS SLC6A2, TPH1, SLC6A3 ALDH1A1 345/4885KDM4E 1194/4885NPC1 701/4885
US-10000450-B2 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors SLC6A2, TPH1, SLC6A3 ALDH1A1 345/4885KDM4E 1194/4885NPC1 701/4885
US-20110065663-A1 ANTI-CANCER COMBINATION THERAPY TYMP, MTAP, NTPCR ALDH1A1 1909/4885KDM4E 1040/4885NPC1 4079/4885
US-20170166524-A1 N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS SLC6A2, TPH1, SLC6A3 ALDH1A1 345/4885KDM4E 1194/4885NPC1 701/4885
US-20120065162-A1 N-N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS SLC6A2, TPH1, SLC6A3 ALDH1A1 380/4885KDM4E 1189/4885NPC1 669/4885
US-20140288065-A1 N,N-SUBSTITUTED 3-AMINOPYRROLIDINE COMPOUNDS USEFUL AS MONOAMINES REUPTAKE INHIBITORS SLC6A2, TPH1, SLC6A3 ALDH1A1 345/4885KDM4E 1194/4885NPC1 701/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback